Question 1

What is Cosmo Pharmaceuticals?

Accepted Answer

Cosmo Pharmaceuticals is a Company.

Question 2

How often does Cosmo Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 14 articles.

Question 3

When was Cosmo Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Jun 11, 2026.

Question 4

When was Cosmo Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Jun 15, 2026.

Question 5

What is Cosmo Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Cosmo Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Cosmo Pharmaceuticals?

Accepted Answer

Cosmo's Winlevi Launches in Europe (Jun 11, 2026, 14 articles).

Question 8

How did the "Cosmo's Winlevi Launches in Europe" event impact Cosmo Pharmaceuticals?

Accepted Answer

Cosmo Pharmaceuticals is the developer and exclusive manufacturer of Winlevi, and its successful launch in Europe through partners like Glenmark Pharmaceuticals and InfectoPharm Arzneimittel und Consilium GmbH is a significant milestone for its dermatology portfolio and global expansion strategy.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.